Piramal Pharma Limited
Piramal Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: PPLPHARMA and BSE: 543635 (ISIN INE0DK501011).
It has a market capitalisation of ₹25,805 crore, a last close of ₹194.44 on 2026-10-19, a one-year return of 0.9%.
Valuation: a price-to-book ratio of 3.16x, a dividend yield of 0.0%.
Profitability: return on equity of -4.0%, return on capital employed of 0.9%, an operating margin of 11.0%.
Growth: sales growth of 7.8% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.67x, promoter holding of 34.8%.
| Metric | Value |
|---|---|
| Market capitalisation | 25,805 |
| Last close | ₹194.44 |
| P/B | 3.16x |
| Dividend yield | 0.0% |
| ROE (FY) | -4.0% |
| ROCE (FY) | 0.9% |
| Operating margin (TTM) | 11.0% |
| Sales growth, 3-year CAGR | 7.8% |
| Debt / equity | 0.67x |
| Promoter holding | 34.8% |
| 1-year return | 0.9% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means